SR

Seema Rawat

Active Director Director DIN 07666243
DIN 07666243 First appointment Feb 2017 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value •••• Premium profile

About Seema Rawat

Data last updated:

Seema Rawat is a Director at Svaj Pharmaceutical Private Limited (since 2017). The company operates in Chemicals and Materials. Svaj Pharmaceutical Private Limited reported revenue of ₹4.16 Cr (FY 2025).

DIN 07666243
Primary Designation Director
Industry Chemicals and Materials
First Appointment 22 Feb 2017
Oldest Company Age 9 yrs
Largest company Svaj Pharmaceutical Private Limited · ₹4.16 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Svaj Pharmaceutical Private Limited U24290MH2017PTC291517
Director22 Feb 20172017₹4.16 Cr (FY 2025)Active

Board colleagues of Seema Rawat

Directorship timeline

Open interactive timeline →
Svaj Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Seema Rawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Rawat

Seema Rawat currently holds 1 directorship: Svaj Pharmaceutical Private Limited (Director, since 22 Feb 2017, revenue ₹4.16 Cr (FY 2025)).

Seema Rawat was first appointed on 22 Feb 2017 as Director at Svaj Pharmaceutical Private Limited.

The current boards of Seema Rawat's companies include Jaikrishna Puransingh Rawat (Svaj Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available